Vanguard Global Advisers, LLC
Position in TLSI — TriSalus Life Sciences, Inc.
CIK 1811242
MALVERN, PA
Position in TLSI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$69,469
+$8,397 QoQ
Shares Held
15,268
0.0% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 83 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TLSI Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Vanguard Global Advisers, LLC holds $1,342,848,846 across 96 Medical Devices names. TLSI ranks #66 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
3,927,717 | $356,401,040 | |
| 2 | SYK |
Stryker Corp
|
744,625 | $234,437,735 | |
| 3 | MDT |
Medtronic plc
|
2,865,007 | $224,129,497 | |
| 4 | BSX |
Boston Scientific Corp
|
3,337,790 | $142,456,877 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,240,852 | $112,247,471 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
981,943 | $62,854,171 | |
| 7 | DXCM |
Dexcom Inc
|
833,079 | $56,107,870 | |
| 8 | STE |
STERIS plc
|
211,869 | $44,613,255 |
All Filings in TLSI
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,469 | 15,268 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $61,072 | 15,268 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||